Zyle 300 Tablet contains Allopurinol 300 mg, a xanthine oxidase inhibitor primarily used to reduce elevated serum uric acid levels in patients with gout and certain types of kidney stones. By inhibiting xanthine oxidase, Allopurinol decreases the production of uric acid, thereby preventing the formation of urate crystals that cause inflammation and pain. This medication is indicated for the management of chronic gout, hyperuricemia associated with malignancy, and prevention of uric acid nephropathy during cancer chemotherapy. Zyle 300 is also utilized in the treatment of recurrent calcium oxalate calculi and in conditions characterized by excessive uric acid production. The tablet is administered orally, typically once daily, with dosage adjustments based on renal function and patient response. Common side effects may include rash, gastrointestinal disturbances, and hypersensitivity reactions; therefore, monitoring for adverse effects is essential. Patients should be advised to maintain adequate hydration to facilitate uric acid excretion. Allopurinol therapy requires careful dose titration and periodic assessment of serum uric acid levels to achieve optimal therapeutic outcomes while minimizing toxicity. It is contraindicated in patients with known hypersensitivity to Allopurinol and should be used cautiously in those with renal or hepatic impairment.